The pill lowers ovarian cancer risk, even for smokers

January 18, 2018

(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial as well.

Long-term use of the was linked to reductions in risk for both cancers, and this was "generally consistent across health behaviors," according to a team led by Kara Michels, a cancer institute epidemiologist.

The researchers looked at data from a U.S. study that tracked the health of from 1995 to 2011. At least 100,000 of the women said they were using an oral contraceptive at the beginning of the study.

Michels' group found a 40 percent reduction in the risk of for women who used the pill for 10 years or more. Furthermore, that benefit was similar for smokers and nonsmokers, and for slim and heavier women, the investigators noted.

As for —tumors of the uterine lining—the benefit was even greater for women with less healthy lifestyle habits.

For example, women who smoked experienced a 53 percent drop in risk for endometrial cancer while on an oral contraceptive. And obese women who were on the pill saw an even greater benefit—a 64 percent reduction in risk for endometrial cancers, the team reported.

However, long-term use of the pill appeared to have no effect on a woman's odds for either breast or colon cancers.

Just how might hormonal contraception shield women from ovarian and endometrial tumors? According to Michels' group, because the pill supplies its own dose of one hormone, progestin, long-term use might then trigger a reduction in a second hormone, estradiol, "across the menstrual cycle."

Exposure to such hormones has been linked to raised rates of certain cancers.

One cancer specialist who reviewed the findings said they expand on existing research.

"This study confirms that long-term use [of the pill] causes a profound reduction in the risk of ovarian and endometrial cancers," said Dr. Stephen Rubin, chief of gynecologic oncology at Fox Chase Cancer Center in Philadelphia.

Ovarian cancer is a "silent killer" because it is often detected only in its later stages. According to the American Cancer Society, more than 22,000 U.S. women will receive a diagnosis of the disease in 2018, and it will claim more than 14,000 lives.

Endometrial cancer is less lethal, but more common. According to the cancer society, more than 63,000 women will be diagnosed with such tumors this year, while about 11,000 will die from the disease.

The new study was published Jan. 18 in JAMA Oncology.

Explore further: Women who take the pill protected from some cancers for up to thirty years

More information: Stephen Rubin, M.D., professor and chief, division of gynecologic oncology, and
Grotzinger-Raab Chair in Surgical Oncology, Fox Chase Cancer Center, Philadelphia; Jan. 18, 2018, JAMA Oncology

Find out more about ovarian cancer at the American Cancer Society.

Related Stories

Women who take the pill protected from some cancers for up to thirty years

March 22, 2017
Women who have taken the oral contraceptive pill are protected from some types of cancer for as long as thirty years according to new research from The University of Aberdeen.

Know the risks, warning signs of ovarian cancer

January 19, 2017
(HealthDay)—Women need to be aware their risk for ovarian cancer increases with age. Half of all cases affect women age 63 or older, according to specialists at Fox Chase Cancer Center in Philadelphia.

Thousands of womb cancers prevented by the pill, study says

August 4, 2015
The contraceptive pill has prevented some 200,000 cases of womb cancer over the last decade in rich nations alone, according to research published Wednesday.

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Risk of endometrial cancer down with intentional weight loss

February 7, 2017
(HealthDay)—Losing weight is associated with a significantly lower risk of endometrial cancer, and that benefit appears to be greatest in obese women, according to a study published online Feb. 6 in the Journal of Clinical ...

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

NEJM reports positive results for larotrectinib against TRK-fusion cancer

February 22, 2018
In 2013, the labs of University of Colorado Cancer Center investigator Robert C. Doebele, MD, PhD, and Dana-Farber Cancer Institute investigator Pasi A. Jänne, MD, PhD reported in Nature Medicine the presence of TRK gene ...

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.